Slide1: Leprosy and the Eye Teaching Set © 1999, revised February 2005 International Centre for Eye Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. Supported by CBM International, Sight Savers International, Tijssen Foundation. INTERNATIONAL CENTRE FOR EYE HEALTH Section 1: Introduction1. What is leprosy and how is leprosy transmitted?: Section 1: Introduction 1. What is leprosy and how is leprosy transmitted? Section 2: Leprosy around the world 2. Leprosy around the world: Section 2: Leprosy around the world 2. Leprosy around the world Section 3: Clinical presentations 3. Clinical presentations : Section 3: Clinical presentations 3. Clinical presentations Section 3: Clinical presentations 4. Paucibacillary Leprosy and Multibacillary Leprosy : Section 3: Clinical presentations 4. Paucibacillary Leprosy and Multibacillary Leprosy Section 4: Skin smear in diagnosis 5. Skin smear in diagnosis : Section 4: Skin smear in diagnosis 5. Skin smear in diagnosis Section 5: Multidrug therapy6. Multidrug therapy: Section 5: Multidrug therapy 6. Multidrug therapy Leprosy treatment regimens Paucibacillary: single skin lesion: 600mg rifampicin single dose 400mg ofloxacin single dose 100mg minocycline single dose Paucibacillary: 2-5 skin lesions: 100mg DDS (dapsone) once daily 600mg rifampicin once per month (supervised monthly: 6 doses to be completed) Multibacillary leprosy: 100mg DDS (dapsone) once daily. 50mg clofazimine (lamprene), once daily. 600mg rifampicin once per month 300mg clofazimine once per month, (supervised monthly: 12 doses to be completed) Section 6: Leprosy7. Reactions (type 1 and type 2): massive infiltration with M. leprae and secondary atrophy: Section 6: Leprosy 7. Reactions (type 1 and type 2): massive infiltration with M. leprae and secondary atrophy Leprosy Top left: Type1 Reversal reaction Top right: Type 2 ENL Reaction Bottom left: Massive infiltration with M. leprae Bottom right: Secondary atrophy Section 7: Treatment of leprosy8. (1) reactions (2) massive infiltration with M. leprae and secondary atrophy: Section 7: Treatment of leprosy 8. (1) reactions (2) massive infiltration with M. leprae and secondary atrophy Slide10: Section 8: Eye complications 9: Eye complications Leprosy: Potentially Blinding Lesions Lagophthalmos (whole spectrum) Corneal hypoaesthesia (whole spectrum) Acute iritis and scleritis (MB leprosy) Chronic iritis and iris atrophy (MB leprosy) Cataract (whole spectrum) Slide11: Section 8: Eye complications 10: Lagophthalmos Slide12: Section 8: Eye complications 11. Treatment of lagophthalmos Duration of lagophthalmos ≤ 6 months: prednisolone 40mg/day slowly reducing over 12 weeks Duration of lagophthalmos > 6 months with eyelid gap < 6 mm: Conservative treatment, e.g sunglasses, 'think blink‘ 3. Duration of lagophthalmos > 6 months with eyelid gap 6 mm: eyelid surgery Slide13: Section 8: Eye complications 12. Lateral Tarsorrhaphy for Lagophthalmos Slide14: Section 8: Eye complications 13. Exposure Keratitis Slide15: Section 8: Eye complications 14. Corneal Hypoaesthesia Slide16: Section 8: Eye complications 15. Type 2 Reaction: Acute Iritis Slide17: Section 8: Eye complications 16. Type 2 Reaction: Acute Episcleritis and Scleritis Slide18: Section 8: Eye complications 17. Massive Bacillary Infiltration: Peri-Orbital Complications Slide19: Section 8: Eye complications 18. Massive Bacillary Infiltration: Ocular Infiltration Slide20: Section 8: Eye complications 19. Massive Bacillary Infiltration: Ocular Atrophic Changes Slide21: Section 9: Leprosy and cataract 20. Leprosy and cataract Slide22: Section 10: Examination of the eyes in leprosy 21. Examination of the eyes in leprosy Slide23: Section 10: Examination of the eyes in leprosy 22. Visual Disability Grading Disability Grade 0: No eye problems due to leprosy; no evidence of visual loss Disability Grade 2: Eye problems due to leprosy present; (1) severe visual impairment (vision worse than 6/60; unable to count fingers at six metres); (2) lagophthalmos; Slide24: Section 11: Patients most at risk of severe eye complications and blindness 23. Patients most at risk of severe eye complications and blindness Slide25: Section 12 24. Prevention of blindness due to leprosy Leprosy: Prevention of Blindness Early diagnosis of leprosy: MDT treatment Early recognition of reactions: effective treatment with systemic steroids Regular eye examination: treatment of any complications Lagophthalmos surgery: all patients with a eyelid gap of ≥ 6 mm Lens extraction: leprosy patients with blinding cataract
NO09 - download at 4shared. NO09 is hosted at free file sharing service 4shared.
Read more
Lieferzeit: 1-4 Tage, Art.Nr.: 06fe no09-bronze. Lesebrille no09 bronze. Steckbügel; Hartschalenetui; Aluminium Fassung; angenehmer Tragekomfort; Entspiegelt;
Read more
Bahntrassenradeln NO09: Ogna – Brusand ... Streckenlänge (einfach): ca. 4,7 km (davon ca. 1,2 km auf der ehem. Bahntrasse)
Read more
Watch videos & listen free to No09: no09, Srez (kiutch mix) & more. Discover more music, concerts, videos, and pictures with the largest catalogue ...
Read more
Thunderbike Harley-Davidson® & Buell Niederrhein in Hamminkeln. Motorräder [Branche editieren] 4.0
Read more
IDEAL MINI Baumwolle Color No09 hellbraun bequem bei puravita.ch kaufen Die Schweizer Online Drogerie Kunden vertrauen auf unsere Fachexpertise!
Read more
Milky Moon ist eine wahre Tee-Köstlichkeit: Ein halbfermentierter Tee, der in einem speziellen Verfahren mit einer Wasser-Molke-Saccharose-Mischung ...
Read more
Pathfinder Maps: Braemar Sheet 255 (NO09/19): Amazon.de: Ordnance Survey: Fremdsprachige Bücher
Read more
The Introduction of Urboun Call Option (UCO).1 Nuradli Ridzwan Shah Bin Mohd Dali Lecturer Faculty of Economy and Muamalat Islamic University College of ...
Read more
Der Oolong Tee von T-Bar - Milky Moon No 09 ist eine wahre Tee-Köstlichkeit: Ein halbfermentierter Oolong Tee mit einem unvergleichlichen Geschmack online ...
Read more
Add a comment